References of "Garraux, Gaëtan"
     in
Bookmark and Share    
Peer Reviewed
See detailExtraction of temporal gait parameters using a reduced number of wearable accelerometers
Boutaayamou, Mohamed ULiege; Denoël, Vincent ULiege; Bruls, Olivier ULiege et al

in Proceedings of the 9th International Conference on Bio-inspired Systems and Signal Processing (2016)

Wearable inertial systems often require many sensing units in order to reach an accurate extraction of temporal gait parameters. Reconciling easy and fast handling in daily clinical use and accurate ... [more ▼]

Wearable inertial systems often require many sensing units in order to reach an accurate extraction of temporal gait parameters. Reconciling easy and fast handling in daily clinical use and accurate extraction of a substantial number of relevant gait parameters is a challenge. This paper describes the implementation of a new accelerometer-based method that accurately and precisely detects gait events/parameters from acceleration signals measured from only two accelerometers attached on the heels of the subject’s usual shoes. The first step of the proposed method uses a gait segmentation based on the continuous wavelet transform (CWT) that provides only a rough estimation of motionless periods defining relevant local acceleration signals. The second step uses the CWT and a novel piecewise-linear fitting technique to accurately extract, from these local acceleration signals, gait events, each labelled as heel strike (HS), toe strike (TS), heel-off (HO), toe-off (TO), or heel clearance (HC). A stride-by-stride validation of these extracted gait events was carried out by comparing the results with reference data provided by a kinematic 3D analysis system (used as gold standard) and a video camera. The temporal accuracy ± precision of the gait events were for HS: 7.2 ms ± 22.1 ms, TS: 0.7 ms ± 19.0 ms, HO: ‒3.4 ms ± 27.4 ms, TO: 2.2 ms ± 15.7 ms, and HC: 3.2 ms ± 17.9 ms. In addition, the occurrence times of right/left stance, swing, and stride phases were estimated with a mean error of ‒6 ms ± 15 ms, ‒5 ms ± 17 ms, and ‒6 ms ± 17 ms, respectively. The accuracy and precision achieved by the extraction algorithm for healthy subjects, the simplification of the hardware (through the reduction of the number of accelerometer units required), and the validation results obtained, convince us that the proposed accelerometer-based system could be extended for assessing pathological gait (e.g., for patients with Parkinson’s disease). [less ▲]

Detailed reference viewed: 230 (16 ULiège)
Full Text
See detailQuestion Intégrative - Médecine - Module Système Nerveux
Pasquet, Coralie ULiege; Van de Poël, Jean-François ULiege; Schaffer, Patrick ULiege et al

Poster (2015, May 18)

Au cours du premier quadrimestre de l’année académique 2014 - 2015, une nouvelle activité a été proposée aux 270 étudiants inscrits en 3ième année du grade de Bachelier en Médecine à l’Université de Liège ... [more ▼]

Au cours du premier quadrimestre de l’année académique 2014 - 2015, une nouvelle activité a été proposée aux 270 étudiants inscrits en 3ième année du grade de Bachelier en Médecine à l’Université de Liège. Cette activité a été réalisée dans le cadre du « Module Système Nerveux ». [less ▲]

Detailed reference viewed: 55 (8 ULiège)
Full Text
Peer Reviewed
See detail[18F]FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model.
Seret, Alain ULiege; Becker, Guillaume ULiege; Bahri, Mohamed Ali ULiege et al

Poster (2015, May 09)

Background: Rat models of Parkinson’s disease (PD), such as lesioned rats with 6-hydroxydopamine (6-OHDA), are useful for studying dopamine (DA)-related functions. 6-[18F]fluoro-m-tyrosine (6-[18F]FMT) is ... [more ▼]

Background: Rat models of Parkinson’s disease (PD), such as lesioned rats with 6-hydroxydopamine (6-OHDA), are useful for studying dopamine (DA)-related functions. 6-[18F]fluoro-m-tyrosine (6-[18F]FMT) is an effective PET tracer to evaluate of DA terminals integrity and L-aromatic amino acid decarboxylase (AAAD) metabolic pathway. However, there are currently no available quantitative PET studies using [18F]FMT in 6-OHDA lesioned rats. In this context, we investigated the feasibility of in vivo PET study using [18F]FMT on 6-OHDA PD’s model. Methods: 10 µg of 6-OHDA were injected into the right medial forebrain bundle (MFB) of male Sprague-Dawley rats (n=8). As control, sham-treated rats (n=8) were injected with vehicle only but otherwise treated identically. Striatal DA presynaptic activity was assessed by dynamic [18F]FMT PET, 30 min after benserazide pretreatment. Structural T2-weighted brain images were acquired on a 9.4T MRI and were used for co-registration. After normalization on a MRI template, kinetic analysis was performed by “Patlak Reference” model, using PMOD software. Results: Striatal accumulation of [18F]FMT was observed in rats pretreated with benserazide, a peripheral AAAD inhibitor. As consequence of the 6-OHDA-lesion, significant decrease of [18F]FMT accumulation was recorded in the striatum ipsilateral to the lesion. Lesioned rats had dramatically reduced uptake constant Ki in the ipsilateral striatum compared to the contralateral striatum (p<0.001) and to the ipsilateral striatum of sham-treated rats (p<0.005). The Ki ratio (Ipsi./Contra.) was equivalent to 94% in the sham group and dropped to 41% in the lesioned group. Conclusions: [18F]FMT PET enables us to quantify loss of DA presynaptic function in unilaterally 6-OHDA lesioned rats. These results encourage us to pursue further investigations in a longitudinal way and to monitor the progression of the dopaminergic dysfunction in more moderate and gradual preclinical PD models. [less ▲]

Detailed reference viewed: 112 (10 ULiège)
Full Text
Peer Reviewed
See detail18F-FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model.
Becker, Guillaume ULiege; Bahri, Mohamed Ali ULiege; Michel, Anne et al

Poster (2015, March 18)

Objectives: Rat models of Parkinson’s disease (PD), such as lesioned rats with 6-hydroxydopamine (6-OHDA), are useful for studying dopamine (DA)-related functions. 6-18F-fluoro-m-tyrosine (6-18F-FMT) is ... [more ▼]

Objectives: Rat models of Parkinson’s disease (PD), such as lesioned rats with 6-hydroxydopamine (6-OHDA), are useful for studying dopamine (DA)-related functions. 6-18F-fluoro-m-tyrosine (6-18F-FMT) is an effective PET tracer to evaluate of DA terminals integrity and L-aromatic amino acid decarboxylase (AAAD) metabolic pathway. However, there are currently no available quantitative PET studies using 18F-FMT in 6-OHDA lesioned rats. In this context, we investigated the feasibility of in vivo PET study using 18F-FMT on 6-OHDA PD’s model. Methods: 10 µg of 6-OHDA were injected into the right medial forebrain bundle (MFB) of male Sprague-Dawley rats (n=8). As control, sham-treated rats (n=8) were injected with vehicle only but otherwise treated identically. Striatal DA presynaptic activity was assessed by dynamic 18F-FMT-PET. Structural T2-weighted brain images were acquired on a 9.4T MRI and were used for co-registration. After normalization on a MRI template, kinetic analysis was performed by “Patlak Reference” model, using PMOD software. Results: Striatal accumulation of 18F-FMT was observed in rats pretreated with benserazide, a peripheral AAAD inhibitor. As consequence of the 6-OHDA-lesion, significant decrease of 18F-FMT accumulation was recorded in the striatum ipsilateral to the lesion. Lesioned rats had dramatically reduced uptake constant Ki in the ipsilateral striatum compared to the contralateral striatum (p<0.001) and to the ipsilateral striatum of sham-treated rats (p<0.005). The Ki ratio (Ipsi./Contra.) was equivalent to 94% in the sham group and dropped to 41% in the lesioned group. Conclusions: 18F-FMT PET enables us to quantify loss of DA presynaptic function in unilaterally 6-OHDA lesioned rats. These results encourage us to pursue further investigations in a longitudinal way and to monitor the progression of the dopaminergic dysfunction in more moderate and gradual preclinical PD models. [less ▲]

Detailed reference viewed: 27 (6 ULiège)
See detailGait quantification through accelerometers and clinical tests: application to pathological gait
DEMONCEAU, Marie ULiege; Boutaayamou, Mohamed ULiege; Maquet, Didier ULiege et al

Conference (2015, January 30)

Gait gives essential information to physiotherapists in the screening and follow-up of their patients suffering from orthopaedic, geriatric or neurologic diseases. Most of time, clinical practitioners ... [more ▼]

Gait gives essential information to physiotherapists in the screening and follow-up of their patients suffering from orthopaedic, geriatric or neurologic diseases. Most of time, clinical practitioners rely on visual observation of their patients during specific clinical tests that can highlight gait abnormalities (e,g., the Tinetti assessment tool, the timed up and go test, the 6 minutes walking test), but these tests provide little quantified information about gait. These rough methods are also limited by inter-rater subjectivity and lack of acuteness in the detection of subtle impairments. On the other hand, instrumented gait analyses offer a sharper investigation with the ability to record and quantify gait events that cannot be caught at simple visual observation. Unfortunately, cutting edge technologies often pay the price of a limited number of strides extracted, the need of a strictly controlled laboratory environment, development and maintenance by a specialized staff. For these reasons, instrumented gait analysis may stand beyond the financial and technical reach of many rehabilitative centres and private practitioners. Accelerometer technologies have considerably developed with the progress of wireless technologies. These lightweight and low-cost sensors allow quantified gait analyses that are not restricted to a laboratory environment but can also be used in medical offices and in combination with common clinical gait tests. This presentation relates the experiences of our departments with accelerometer systems and clinical testing in gait analysis of patients suffering from Parkinson’s disease. The aim of this intervention is to cross ideas and knowledge of clinical practitioners and engineers in the development a new gait analysis tool that could integrate routine evaluation of patients suffering from Parkinson’s disease and other conditions characterized by gait impairments. [less ▲]

Detailed reference viewed: 50 (8 ULiège)
Full Text
See detailProtocol Optimization for Alpha–Synuclein Immuno-Labeling in the Autonomous Nervous System in Parkinson’s Disease
Pasquet, Coralie ULiege; Garraux, Gaëtan ULiege; Borgs, Laurence ULiege et al

Scientific conference (2015, January 27)

Reviewing and testing of published protocols for the immuno-labelling of α–synuclein in the autonomous nervous system in Parkinson’s disease.

Detailed reference viewed: 29 (5 ULiège)
Full Text
See detailEffects of α-synuclein levels on cerebral synaptic function: Validation of a novel PET radioligand for the early diagnosis of Parkinson’s disease
Tarragon Cros, Ernesto ULiege; Ferrara, André ULiege; Tirelli, Ezio ULiege et al

Poster (2015, January 27)

Background In Parkinson’s disease, converging evidence supports a pathogenic role for excessive α–synuclein accumulation in synaptic terminals that may propagate back to the soma of vulnerable nerve cells ... [more ▼]

Background In Parkinson’s disease, converging evidence supports a pathogenic role for excessive α–synuclein accumulation in synaptic terminals that may propagate back to the soma of vulnerable nerve cells such as neurons in the substantia nigra pars compacta. The resulting loss of dopaminergic terminals in the striatum can be demonstrated in vivo using 18F-Dopa-PET (positron emission tomography). However, there’s currently no validated biomarker of the progressive synaptic dysfunction in other vulnerable areas such as the cerebral cortex. Goal In this longitudinal study, we will test the hypothesis that the loss of synaptic terminals in a mouse model of excessive α–synuclein accumulation can be demonstrated in vivo before the occurrence of behavioural disturbances using 18F-UCB-H, a new PET biomarker developed at CRC. We will also test if this new imaging modality is sensitive enough to study the effect of a disease modifying therapy such as chronic physical exercise. Methods We will use microPET for the in vivo quantification of 18F-UCB-H brain uptake in 16 wild type animals and 16 transgenic (Tg) mice overexpressing human α–syn under the mThy1 promotor every 2 months. Data will be validated against post-mortem analyses after the last PET study. Predictions We predict decreased tracer uptake over time in the basal ganglia and cerebral cortex in Tg mice as compared with WT animals. Also, we predict a relationship between 18F-UCB-H uptake levels in basal ganglia and cerebral cortex and progressive alterations in both motor and cognitive functions, respectively. Further, we also expect that chronic exercise will slow down both motor and cognitive disturbances, as well as the rate of 18F-UCB-H brain uptake decreases. Conclusion If 18F-UCB-H PET proves to be a valid biomarker for the early detection of α–synuclein accumulation in the pre-clinical model of PD, the methods will tested on human clinical populations. [less ▲]

Detailed reference viewed: 181 (23 ULiège)
See detailDéveloppement de nouveaux marqueurs neuroradiologiques de la maladie de Parkinson par reconnaissance de motifs
Himri, Khadidja ULiege; Depierreux, Frédérique ULiege; GARRAUX, Gaëtan ULiege

Poster (2015, January 27)

Background and objectives: Automatic classification of Parkinson’s disease (PD) versus healthy controls (HC) based on structural MRI has so far focused on unimodal approaches. However, this method is ... [more ▼]

Background and objectives: Automatic classification of Parkinson’s disease (PD) versus healthy controls (HC) based on structural MRI has so far focused on unimodal approaches. However, this method is subject to a poor temporal and spatial resolution leading to low classification accuracy. To overcome this limitation we propose to integrate different modalities by generating a single decision function based on a multi-kernel method, exploiting the complementary information it offers. We predict that the integration of multiple modalities produces greater classification enhancement. Materials and methods: 3Tesla MRI was acquired in 42 patients with PD and 42 age and gender matched healthy controls. We relied on Unified Parkinson’s Disease Rating Scale (UPDRS) for evaluating the clinical status. We used structural and quantitative maps of T1, T2*, proton density (PD), magnetization transfer (MT), Multi-parameter (MT magnetization transfer, proton density (A), Iron Deposit (R2 *), mixing water content, iron, and the fraction of macromolecules tissues (R1) at 1 × 1 × 1 mm3 resolution. We identified cortical and subcortical brain regions (cortex, putamen, globus pallidus, substantia nigra), and cortical grey matter. We applied existing classification algorithms in the field of neuroscience using a classification algorithm based on Support Vector Machines (SVMs) [1], executed using the Pattern Recognition for Neuroimaging Toolbox (PRoNTo) [2]. The processes of classification was the following, data were mean centered and leave one subject out cross-validation was performed, making the test set independent from the training set. Analyses were restricted to voxels where all subjects had non-zero values. Statistical significance of the classifications was tested using permutation testing (1000 permutations) with random assignment of group class to the input image. Subsequently, we combined different modalities (MT, A, R1, R2) and identified the combination giving the highest sensitivity and sensibility in PD classification. As classifier we used support vector machines that are inspired by statistical learning theory Vladimir Vapnik and Multiple Kernel Learning approach, introduced by Lanckriet [3],[4]. Our approach can be seen as an analogue of MKL with SVMs. Conclusion & Future work: Identification of brain areas with affected intensity in the Parkinson’s group compared to Healthy Controls in single modalities using pronto is helpful. However, the subsequent multi-kernel approach utilizes unimodal information in a combined fashion so that emergent information is obtained, transcending effectiveness unimodal approaches. In conclusion, our findings suggest that combining different imaging modalities and different regions of interest increase classification accuracy significantly. These results are promising for objective diagnosis in medical practice. [less ▲]

Detailed reference viewed: 68 (9 ULiège)
See detailComparison of brain functional connectivity methods for the diagnosis of Parkinson’s disease using resting state fMRI
Baquero Duarte, Katherine Andrea ULiege; Rouillard, Maud; Depierreux, Frédérique ULiege et al

Scientific conference (2015, January 27)

Background In the absence of validated biomarkers, the early diagnosis of Parkinson’s disease (PD), the second most common neurodegenerative disorder worldwide [1], is challenging and is prone to low ... [more ▼]

Background In the absence of validated biomarkers, the early diagnosis of Parkinson’s disease (PD), the second most common neurodegenerative disorder worldwide [1], is challenging and is prone to low accuracy [2]. Recent evidence suggests that the average pattern of functional connectivity (FC) between the basal ganglia and cerebral cortex assessed in the resting state using functional magnetic resonance imaging (rs-fMRI) might discriminate between mild PD and healthy controls with 85% overall accuracy [3]. Goal We will test if this finding can be replicated in our population. We will also compare the diagnosis accuracy of this approach, which depicts an average pattern of connectivity during the whole scanning period, with that of dynamic FC that investigates the spontaneous fluctuations of the pattern of connectivity over the scanning period [4]. Methods We are currently processing and analyzing rs-fMRI data prospectively acquired on a 3T MRI in 39 patients with PD (mean disease duration 5.4 years; mean Hoehn and Yahr stage 1.5) and 39 healthy controls matched for age, gender and levels of education. For dynamic FC we will compare two different methods [4], one that use slice-time windows to capture brain dynamics with another that captures spatial co-activation patters (CAPs) at specific time points. Conclusion The selected methods will be further validated in a new cohort of de novo drug-naïve PD patients. [1] Tessitore, A., et al. Sensorimotor connectivity in Parkinson’s disease: the role of functional neuroimaging. Frontiers in neurology 5 (2014). [2] Adler et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease. Clinicopathologic study. Neurology 2014;83:406–412 [3] Szewczyk-Krolikowski, K., et al. Functional connectivity in the basal ganglia network differentiates PD patients from controls. Neurology 83.3 (2014): 208-214. [4] Hutchison, M., et al. Dynamic functional connectivity: promise, issues, and interpretations. Neuroimage 80 (2013): 360-378. [less ▲]

Detailed reference viewed: 125 (14 ULiège)
Full Text
Peer Reviewed
See detailDevelopment and validation of an accelerometer-based method for quantifying gait events
Boutaayamou, Mohamed ULiege; Schwartz, Cédric ULiege; Stamatakis, Julien et al

in Medical Engineering & Physics (2015)

An original signal processing algorithm is presented to automatically extract, on a stride-by-stride basis, four consecutive fundamental events of walking, heel strike (HS), toe strike (TS), heel-off (HO ... [more ▼]

An original signal processing algorithm is presented to automatically extract, on a stride-by-stride basis, four consecutive fundamental events of walking, heel strike (HS), toe strike (TS), heel-off (HO), and toe-off (TO), from wireless accelerometers applied to the right and left foot. First, the signals recorded from heel and toe three-axis accelerometers are segmented providing heel and toe flat phases. Then, the four gait events are defined from these flat phases. The accelerometer-based event identification was validated in seven healthy volunteers and a total of 247 trials against reference data provided by a force plate, a kinematic 3D analysis system, and video camera. HS, TS, HO, and TO were detected with a temporal accuracy ± precision of 1.3 ms ± 7.2 ms, ‒4.2 ms ± 10.9 ms, ‒3.7 ms ± 14.5 ms, and ‒1.8 ms ± 11.8 ms, respectively, with the associated 95% confidence intervals ranging from ‒6.3 ms to 2.2 ms. It is concluded that the developed accelerometer-based method can accurately and precisely detect HS, TS, HO, and TO, and could thus be used for the ambulatory monitoring of gait features computed from these events when measured concurrently in both feet. [less ▲]

Detailed reference viewed: 215 (21 ULiège)
Full Text
Peer Reviewed
See detailDevelopment and validation of a 3D kinematic-based method for determining gait events during overground walking
Boutaayamou, Mohamed ULiege; Schwartz, Cédric ULiege; Denoël, Vincent ULiege et al

in IEEE International Conference on 3D Imaging (IC3D) (2015)

A new signal processing algorithm is developed for quantifying heel strike (HS) and toe-off (TO) event times solely from measured heel and toe coordinates during overground walking. It is based on a rough ... [more ▼]

A new signal processing algorithm is developed for quantifying heel strike (HS) and toe-off (TO) event times solely from measured heel and toe coordinates during overground walking. It is based on a rough estimation of relevant local 3D position signals. An original piecewise linear fitting method is applied to these local signals to accurately identify HS and TO times without the need of using arbitrary experimental coefficients. We validated the proposed method with nine healthy subjects and a total of 322 trials. The extracted temporal gait events were compared to reference data obtained from a force plate. HS and TO times were identified with a temporal accuracy ± precision of 0.3 ms ± 7.1 ms, and –2.8 ms ± 7.2 ms in comparison with reference data defined with a force threshold of 10 N. This algorithm improves the accuracy of the HS and TO detection. Furthermore, it can be used to perform stride-by-stride analysis during overground walking with only recorded heel and toe coordinates. [less ▲]

Detailed reference viewed: 84 (9 ULiège)
Full Text
Peer Reviewed
See detailLarge Scale Assessment of Polyglutamine Repeat Expansions in Parkinson Disease
Wang, Lisa; Aasly, Jan; Anesi, Grazia et al

in Neurology (2015), 85(15), 1283-1292

Objectives: We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD). Methods: We invited ... [more ▼]

Objectives: We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD). Methods: We invited researchers from the Genetic Epidemiology of Parkinson's Disease Consortium to participate in the study. There were 12,346 cases and 8,164 controls genotyped, for a total of 4 repeats within the SCA2, SCA3, SCA6, and SCA17 genes. Fixed- and random-effects models were used to estimate the summary risk estimates for the genes. We investigated between-study heterogeneity and heterogeneity between different ethnic populations. Results: We did not observe any definite pathogenic repeat expansions for SCA2, SCA3, SCA6, and SCA17 genes in patients with idiopathic PD from Caucasian and Asian populations. Furthermore, overall analysis did not reveal any significant association between intermediate repeats and PD. The effect estimates (odds ratio) ranged from 0.93 to 1.01 in the overall cohort for the SCA2, SCA3, SCA6, and SCA17 loci. Conclusions: Our study did not support a major role for definite pathogenic repeat expansions in SCA2, SCA3, SCA6, and SCA17 genes for idiopathic PD. Thus, results of this large study do not support diagnostic screening of SCA2, SCA3, SCA6, and SCA17 gene repeats in the common idiopathic form of PD. Likewise, this largest multicentered study performed to date excludes the role of intermediate repeats of these genes as a risk factor for PD. [less ▲]

Detailed reference viewed: 10 (0 ULiège)
Peer Reviewed
See detailSegmentation of gait cycles using foot-mounted 3D accelerometers
Boutaayamou, Mohamed ULiege; Bruls, Olivier ULiege; Denoël, Vincent ULiege et al

in Proceedings of the IEEE International Conference on 3D Imaging 2015 (2015)

We describe a new gait segmentation method based on the continuous wavelet transform to identify stride-by-stride gait cycles from measurements of foot-mounted three-dimensional (3D) accelerometers. The ... [more ▼]

We describe a new gait segmentation method based on the continuous wavelet transform to identify stride-by-stride gait cycles from measurements of foot-mounted three-dimensional (3D) accelerometers. The detection of such gait cycles is indeed a crucial step for an accurate extraction of relevant gait events such as heel strike, toe strike, heel-off, and toe-off. We demonstrate the ability of this segmentation method, used in conjunction with a validated extraction algorithm, to calculate the following gait (duration) parameters for each gait cycle during the gait of a healthy young subject and of an elderly subject with Parkinson’s disease (PD) in OFF and ON states: durations of (1) loading response, (2) mid-stance, (3) push-off, (4) stance, (5) swing, (6) stride, (7) step, and (8) double support phases. The experimental results show that the proposed method can extract relevant refined gait parameters to quantify subtle gait disturbances in subjects with PD. [less ▲]

Detailed reference viewed: 57 (2 ULiège)
Full Text
Peer Reviewed
See detailContribution of a Trunk Accelerometer System to the Characterization of Gait in Patients With Mild-to-Moderate Parkinson’s Disease
Demonceau, Marie ULiege; Donneau, Anne-Françoise ULiege; CROISIER, Jean-Louis ULiege et al

in IEEE Journal of Biomedical and Health Informatics (2015)

OBJECTIVE: Gait disturbances like shuffling and short steps are obvious at visual observation in patients with advanced Parkinson's disease (PD). However, quantitative methods are increasingly used to ... [more ▼]

OBJECTIVE: Gait disturbances like shuffling and short steps are obvious at visual observation in patients with advanced Parkinson's disease (PD). However, quantitative methods are increasingly used to evaluate the wide range of gait abnormalities that may occur over the disease course. The goal of this study was to test the ability of a trunk accelerometer system to quantify the effects of PD on several gait features when walking at self-selected speed. METHODS: We recruited 96 subjects split into three age-matched groups: 32 healthy controls (HC), 32 PD patients at Hoehn and Yahr stage < II (PD-1), and 32 patients at Hoehn & Yahr stage II-III (PD-2). The following outcomes were extracted from the signals of the tri-axial accelerometer worn on the lower back: stride length, cadence, regularity index, symmetry index and mechanical powers yielded in the cranial-caudal, antero-posterior and medial-lateral directions. Walking speed was measured using a stopwatch. RESULTS: beside other gait features, the PD-1 and the PD-2 groups showed significantly reduced stride length normalized to height (p<0.02) and symmetry index (p<0.009) in comparison to the HC. Regularity index was the only feature significantly decreased in the PD-2 group as compared with the two other groups (p<0.01). The clinical relevance of this finding was supported by significant correlations with mobility and gait scales (r is around -0.3; p<0.05). CONCLUSION: Gait quantified by a trunk accelerometer may provide clinically useful information for the screening and follow-up of PD patients. [less ▲]

Detailed reference viewed: 49 (10 ULiège)
Peer Reviewed
See detailAmbulatory system using wearable accelerometers for gait analysis in Parkinson’s disease
Boutaayamou, Mohamed ULiege; Demonceau, Marie ULiege; Schwartz, Cédric ULiege et al

in Proceedings of the 14th Belgian Day on Biomedical Engineering (2015)

We describe a signal-processing algorithm for gait analysis in Parkinson’s disease (PD) using an ambulatory system with wearable accelerometers. This algorithm is versatile enough to detect, on a stride ... [more ▼]

We describe a signal-processing algorithm for gait analysis in Parkinson’s disease (PD) using an ambulatory system with wearable accelerometers. This algorithm is versatile enough to detect, on a stride-by-stride basis, refined gait parameters that quantify subtle gait disturbances in PD in a rater-independent way. [less ▲]

Detailed reference viewed: 64 (0 ULiège)